APA (7th ed.) Citation

Hoch, D., Rabaglio, M., Grob, T., von Gunten, M., Beyer, J., & Akhoundova, D. (2023). Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report. Case Reports in Oncology, 16(1), 1280. https://doi.org/10.1159/000534177

Chicago Style (17th ed.) Citation

Hoch, Dennis, Manuela Rabaglio, Tobias Grob, Michael von Gunten, Jörg Beyer, and Dilara Akhoundova. "Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report." Case Reports in Oncology 16, no. 1 (2023): 1280. https://doi.org/10.1159/000534177.

MLA (9th ed.) Citation

Hoch, Dennis, et al. "Exceptional Response to Pembrolizumab in a Mismatch Repair-Deficient Aggressive Prostate Cancer with Somatic EPCAM, MSH2, and MSH6 Co-Deletion: A Case Report." Case Reports in Oncology, vol. 16, no. 1, 2023, p. 1280, https://doi.org/10.1159/000534177.